Glioma cells use multiple strategies to suppress immune responses, such as downregulating their own MHC-I complexes, as well as increasing the expression of immune checkpoint regulators, such as PD-1 and PD-L1 [42]. Here, PDCD1 is linked to central nervous system cancer.